CIK 0001420720 · Non-accelerated filer<br>Smaller reporting company
iBio, Inc.
Sign in to watch- Ticker
- IBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262797813
- Phone
- 302 355-0650
- Business address
- 600 MADISON AVENUE, SUITE 1601, NEW YORK, NY, 10022-1737
- Former names
- iBio, Inc., iBioPharma, Inc., InB:Biotechnologies, Inc.
- UPLOAD Other SEC-generated Letter
- D Other Notice of Sales of Unregistered Securities
- DEF 14A Proxy Proxy Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 8-K Event Executive or director change
- 8-K Event Material agreement · Unregistered share sale
- PRE 14A Proxy Proxy Statement (Preliminary)
- 10-K Report Annual Report
- NT 10-K Other NT 10-K
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- S-1 Offering Registration Statement
- 8-K Event Regulation FD disclosure
- 424B3 Offering Prospectus
Page 42 of 46 · 911 filings